Randomized phase III trials of second-line chemotherapy in patients with advanced bladder cancer: progress and pitfalls

Ann Oncol. 2011 Feb;22(2):245-7. doi: 10.1093/annonc/mdq684.
No abstract available

Publication types

  • Clinical Trial, Phase III
  • Editorial
  • Randomized Controlled Trial

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Humans
  • Prognosis
  • Survival Analysis
  • Urinary Bladder Neoplasms / drug therapy*

Substances

  • Antineoplastic Agents